ReviewMarine drugs2025
Chemical Defenses in Medusozoa.
Review in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cnidarian defensive strategies are commonly associated with the toxins they synthesize. Because toxins have negative, sometimes lethal, effects on humans, research has focused on them for medical and biotechnological applications. However, Cnidaria possess a variety of defensive systems complementing toxins. In recent decades, ecological and biotechnological studies have shed light on these systems, particularly in Anthozoa, while the knowledge of defensive systems different from toxins has remained limited in Medusozoa (Cubozoa, Hydrozoa, Scyphozoa and Staurozoa). In this review, we collected the scattered information available in the literature and organized it into four main topics: UV-light protection compounds, antioxidants, antimicrobial peptides, and endosymbionts. Within the topics, we found the largest amount of data refers to antimicrobial activities, which suggests this line of research as a potential exploitation of this group of organisms often appearing in large aggregates. We also found that some Medusozoa have been studied in detail as model organisms, although the close phylogenetic relationship among classes suggests that some defensive strategies may be common to other members of different classes. Indeed, an integrated understanding of defensive systems has the potential to inform not only ecological and evolutionary frameworks, but also biotechnological applications-from the identification of novel antioxidants or antimicrobial agents to the valorization of Medusozoan biomass.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.